Are Atherogenic Lipoprotein Phenotype and Inflammation Indicative of Plaque Phenotype and Clinical Stability in Coronary Artery Disease?

Are Atherogenic Lipoprotein Phenotype and Inflammation Indicative of Plaque Phenotype and Clinical Stability in Coronary Artery Disease?—Reply

Published:2019-09-01 Issue:9 Volume:4 Page:951
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Vergallo Rocco¹,Porto Italo²,Crea Filippo¹

Affiliation:

1. Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, Università Cattolica Sacro Cuore, Rome, Italy

2. Cardiovascular Unit, Department of Internal Medicine and Specialties (DIMI), Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico San Martino, Università di Genova, Genova, Italy

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2738102/jamacardiology_vergallo_2019_lr_190015.pdf

Reference6 articles.

1. Coronary atherosclerotic phenotype and plaque healing in patients with recurrent acute coronary syndromes compared with patients with long-term clinical stability: an in vivo optical coherence tomography study.;Vergallo;JAMA Cardiol,2019

2. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.;Liuzzo;N Engl J Med,1994

3. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.;Ridker;Lancet,2018

4. Optical coherence tomography and C-reactive protein in risk stratification of acute coronary syndromes.;Fracassi;Int J Cardiol,2019

5. Triglyceride-to-high-density lipoprotein cholesterol ratio and vulnerable plaque features with statin therapy in diabetic patients with coronary artery disease: frequency-domain optical coherence tomography analysis.;Takata;JACC Cardiovasc Imaging,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF Patients;Journal of Clinical Medicine;2023-07-27

2. Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-03-09

3. Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial;Clinical Research in Cardiology;2023-01-14

4. Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial;2022-10-28

5. Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial;Biomedicines;2022-09-15